Government Intervention in response to the mounting concern over the over prescription of antibiotics, the government has moved pro-actively. This is a serious problem since using antibiotics excessively might result in the development of antimicrobial resistance (AMR), which reduces the effectiveness of these medications in treating illnesses.
All medical college doctors have received a directive from Dr. Atul Goel, the Director General of Health Services. The directive places a strong emphasis on the necessity for physicians to prescribe antibiotics with a clear indication, rationale, or explanation. This means that when prescribing antibiotics, medical professionals need to be specific about the illness or rationale for the medication.
An Appeal by Letter Dr. Goel’s correspondence is sent as a letter to medical practitioners. In this letter, physicians are asked to follow the new mandate and give thorough explanations of why antibiotics are required in their prescriptions.
Awareness of Antimicrobial Resistance (AMR)letter draws attention to the serious repercussions of Antimicrobial Resistance (AMR) worldwide. When bacteria, or other microorganisms, develop resistance to the actions of antimicrobial drugs like antibiotics, AMR takes place. One of the main factors contributing to the development of AMR is the overuse and misuse of antibiotics.
Importance of Cautionary Antibiotic Use highlights the significance of cautious antibiotic use in light of the scarcity of new antibiotics being developed at this time.
Pharmacist Reminder that Schedule H and H1 of the Drugs and Cosmetics Rules are among the regulations that pharmacists should remember to follow in addition to doctors. This emphasizes the necessity of responsible antibiotic distribution by restricting the sale of antibiotics to those with legitimate prescriptions.
The letter emphasizes that one of the biggest challenges to global public health is antimicrobial resistance, or AMR. Stats on the direct and indirect mortality caused by bacterial AMR are cited, highlighting how urgent it is to address the problem.
Dr. Goel emphasizes the vital role medical colleges play in training the next generation of physicians as well as in delivering healthcare. In order to ensure that future physicians handle antibiotics responsibly, the appeal aims to understand the importance of addressing the crisis of antimicrobial resistance.
Under the Union Health Ministry, the DGHS is a significant agency. In India, developing and carrying out health policies and initiatives is within the purview of the Union Health Ministry. As a division of this ministry, the DGHS is vital to the planning, direction, and control of numerous health-related endeavors.
Regulatory Measures Specific regulatory requirements governing the sale and distribution of medications, including antibiotics, are indicated by the reference to “Schedule H and H1 of the Drugs and Cosmetics Rules”. The prescribing and dispensing of antibiotics and other specific medication classes are governed by Schedule H and H1 in India. The purpose of these restrictions is to guarantee that these drugs are only taken sparingly and under the guidance of licensed healthcare professionals.
The data emphasizes that in addition to directing physicians, the DGHS, represented by Dr. Atul Goel, has also reminded pharmacists of their part in carrying out these regulatory procedures. Antibiotics should only be sold by pharmacists with legitimate prescriptions from certified medical specialists, it is advised.
One of the most important ways to stop the indiscriminate use of antibiotics is to sell them only to people with legal prescriptions. Proper prescriptions guarantee that antibiotics are administered after a careful evaluation of the patient’s status by a licensed healthcare provider, taking into consideration the particular medical necessity.
The letter emphasizes how crucial it is for physicians to include the precise indication—that is, the reason why an antibiotic is being prescribed—on the prescription. This prerequisite adds one more layer of accountability, as it encourages doctors to clearly document the medical necessity for the use of antibiotics.
The data emphasizes that in addition to directing physicians, the DGHS, represented by Dr. Atul Goel, has also reminded pharmacists of their part in carrying out these regulatory procedures. Antibiotics should only be sold by pharmacists with legitimate prescriptions from certified medical specialists, it is advised.
One of the most important ways to stop the indiscriminate use of antibiotics is to sell them only to people with legal prescriptions. Proper prescriptions guarantee that antibiotics are administered after a careful evaluation of the patient’s status by a licensed healthcare provider, taking into consideration the particular medical necessity.
The letter emphasizes how crucial it is for physicians to include the precise indication—that is, the reason why an antibiotic is being prescribed—on the prescription. “It is estimated that bacterial AMR was directly responsible for 1.27 million global deaths in 2019, and 4.95 million deaths were merely associated with drug-resistant infections,” the letter continues.
According to the letter, “AMR jeopardizes many of the advancements in contemporary medicine. It puts at risk the efficient management and prevention of infections brought on by resistant bacteria, increasing the likelihood of a protracted illness and even death. Longer periods of interactivity are another consequence of treatment failures, and many people may not be able to receive these medications due to their exorbitant cost.”Goel emphasizes the value of medical colleges even more in his letter, stating that it is an appeal because “medical colleges serve as centers for the education of the next generation of doctors in addition to offering tertiary healthcare in the nation.” For this reason, it is crucial that medical college faculty members serve as role models for the future generation of medical professionals, who will have to deal with this situation in a far more dire way.
Aurobindo Pharma subsidiary wins CDSCO approval for medication to treat breast cancer; provide context
